Unexpected Fat Distribution in Adolescents With Narcolepsy

Area of Science:

• Endocrinology
• Neurology
• Metabolic Health

Background:

• Narcolepsy type 1 is linked to increased BMI in adolescents, raising metabolic syndrome risks.
• The precise body fat distribution and weight gain mechanisms in narcolepsy remain unclear, potentially involving orexin pathway dysfunction.
• Orexin's role in regulating brown adipose tissue (BAT) suggests a possible link to altered energy homeostasis in narcolepsy.

Purpose of the Study:

• To investigate adipose tissue distribution in adolescent patients with narcolepsy type 1.
• To compare fat distribution patterns between narcolepsy patients and healthy controls.
• To explore the potential influence of orexin deficiency on BAT and abdominal fat partitioning.

Main Methods:

• Utilized full-body magnetic resonance imaging (MRI) to assess adipose tissue distribution.
• Compared 19 adolescent narcolepsy type 1 patients with 17 healthy adolescent peers.
• Quantified total fat, supraclavicular BAT, total abdominal adipose tissue (TAAT), visceral adipose tissue (VAT), and subcutaneous abdominal adipose tissue (ASAT).

Main Results:

• Narcolepsy patients exhibited higher overall body fat compared to controls.
• No significant group differences were found in supraclavicular BAT volume.
• Patients with narcolepsy had increased TAAT but a lower VAT/TAAT ratio, indicating a relative increase in ASAT.

Conclusions:

• Weight gain in adolescents with narcolepsy type 1 resembles central obesity patterns.
• The observed lower VAT/TAAT ratio in narcolepsy patients may suggest a reduced risk for developing metabolic diseases.
• Orexin may not significantly impact BAT under thermoneutral conditions, contrary to hypotheses.